 |
PDBsum entry 3e9b
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Biochemistry
48:121-131
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Probing the specificity determinants of amino acid recognition by arginase.
|
|
E.Y.Shishova,
L.Di Costanzo,
F.A.Emig,
D.E.Ash,
D.W.Christianson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Arginase is a binuclear manganese metalloenzyme that serves as a therapeutic
target for the treatment of asthma, erectile dysfunction, and atherosclerosis.
In order to better understand the molecular basis of inhibitor affinity, we have
employed site-directed mutagenesis, enzyme kinetics, and X-ray crystallography
to probe the molecular recognition of the amino acid moiety (i.e., the
alpha-amino and alpha-carboxylate groups) of substrate l-arginine and inhibitors
in the active site of arginase I. Specifically, we focus on (1) a water-mediated
hydrogen bond between the substrate alpha-carboxylate and T135, (2) a direct
hydrogen bond between the substrate alpha-carboxylate and N130, and (3) a direct
charged hydrogen bond between the substrate alpha-amino group and D183. Amino
acid substitutions for T135, N130, and D183 generally compromise substrate
affinity as reflected by increased K(M) values but have less pronounced effects
on catalytic function as reflected by minimal variations of k(cat). As with
substrate K(M) values, inhibitor K(d) values increase for binding to enzyme
mutants and suggest that the relative contribution of intermolecular
interactions to amino acid affinity in the arginase active site is
water-mediated hydrogen bond < direct hydrogen bond < direct charged
hydrogen bond. Structural comparisons of arginase with the related binuclear
manganese metalloenzymes agmatinase and proclavaminic acid amidinohydrolase
suggest that the evolution of substrate recognition in the arginase fold occurs
by mutation of residues contained in specificity loops flanking the mouth of the
active site (especially loops 4 and 5), thereby allowing diverse guanidinium
substrates to be accommodated for catalysis.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Di Costanzo,
M.Ilies,
K.J.Thorn,
and
D.W.Christianson
(2010).
Inhibition of human arginase I by substrate and product analogues.
|
| |
Arch Biochem Biophys,
496,
101-108.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.E.Fallang,
E.Bergseng,
K.Hotta,
A.Berg-Larsen,
C.Y.Kim,
and
L.M.Sollid
(2009).
Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.
|
| |
Nat Immunol,
10,
1096-1101.
|
 |
|
|
|
|
 |
M.Aschner,
K.M.Erikson,
E.H.Hernández,
and
R.Tjalkens
(2009).
Manganese and its role in Parkinson's disease: from transport to neuropathology.
|
| |
Neuromolecular Med,
11,
252-266.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |